- Home
- SDGR vs IMCR Comparison
SDGR vs IMCR Comparison
Compare SDGR & IMCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SDGR
- IMCR
- Stock Information
- Founded
- SDGR 1990
- IMCR 2008
- Country
- SDGR United States
- IMCR United Kingdom
- Employees
- SDGR N/A
- IMCR N/A
- Industry
- SDGR Biotechnology: Pharmaceutical Preparations
- IMCR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SDGR Health Care
- IMCR Health Care
- Exchange
- SDGR Nasdaq
- IMCR Nasdaq
- Market Cap
- SDGR 1.8B
- IMCR 1.5B
- IPO Year
- SDGR 2020
- IMCR 2021
- Fundamental
- Price
- SDGR $22.64
- IMCR $29.92
- Analyst Decision
- SDGR Buy
- IMCR Buy
- Analyst Count
- SDGR 9
- IMCR 13
- Target Price
- SDGR $32.11
- IMCR $65.18
- AVG Volume (30 Days)
- SDGR 1.0M
- IMCR 158.6K
- Earning Date
- SDGR 02-26-2025
- IMCR 02-26-2025
- Dividend Yield
- SDGR N/A
- IMCR N/A
- EPS Growth
- SDGR N/A
- IMCR N/A
- EPS
- SDGR N/A
- IMCR N/A
- Revenue
- SDGR $193,348,000.00
- IMCR $296,312,000.00
- Revenue This Year
- SDGR N/A
- IMCR $28.89
- Revenue Next Year
- SDGR $31.43
- IMCR $13.00
- P/E Ratio
- SDGR N/A
- IMCR N/A
- Revenue Growth
- SDGR N/A
- IMCR 25.09
- 52 Week Low
- SDGR $16.67
- IMCR $27.69
- 52 Week High
- SDGR $33.63
- IMCR $72.56
- Technical
- Relative Strength Index (RSI)
- SDGR 43.67
- IMCR 47.96
- Support Level
- SDGR $23.14
- IMCR $28.41
- Resistance Level
- SDGR $28.47
- IMCR $30.49
- Average True Range (ATR)
- SDGR 1.60
- IMCR 1.47
- MACD
- SDGR -0.34
- IMCR -0.07
- Stochastic Oscillator
- SDGR 9.19
- IMCR 41.03
About SDGR Schrodinger Inc.
Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.
About IMCR Immunocore Holdings plc
Immunocore Holdings PLC is a late-stage biotechnology company engaged in the development of a novel class of TCR bispecific immunotherapies for the treatment of cancer, infectious and autoimmune diseases. Its geographical segments are the United Kingdom and the United States, of which the majority of its revenue comes from the United States.